MedTrace Logo

Registry on Percutaneous Electrochemotherapy

NCT05267080 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-02-06

No results posted yet for this study

Summary

The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy (ECT) for the treatment of liver cancer.

Conditions

  • Primary Liver Cancer
  • Secondary Liver Cancer

Interventions

DEVICE

CLINIPORATOR

The CLINIPORATOR is used to perform percutaneous electrochemotherapy on liver tumours.

Sponsors & Collaborators

  • Cardiovascular and Interventional Radiological Society of Europe

    lead OTHER

Principal Investigators

  • Philipp Wiggermann, Prof. Dr. · Städtisches Klinikum Braunschweig, Braunschweig, Germany

  • Attila Kovács, PD. Dr. med. · WEGE Klinik, Bonn, Germany

  • Franco Orsi, Prof. · European Institute of Oncology, Milan, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-25
Primary Completion
2026-01-23
Completion
2027-01-31

Countries

  • France
  • Germany
  • Hungary
  • Italy
  • Lithuania
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05267080 on ClinicalTrials.gov